Role of extracellular domain dimerization in agonist-induced activation of natriuretic peptide receptor A

Molecular Pharmacology

Volumn 73, Issue 2, 2008, Pages 431-440

  Parat, Marie ^a   McNicoll, Normand ^a   Wilkes, Brian ^b   Fournier, Alain ^c   De Léan, André ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGINYL BETA CYCLOHEXYL ALANYL TIC ARGINYLCYSTEINAMIDE; ARGINYLLEUCYLSERYLLEUCINE; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE RECEPTOR A; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DIMERIZATION; DOSE RESPONSE; FLUORESCENCE RESONANCE ENERGY TRANSFER; LIGAND BINDING; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

EID: 38549143915     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.039982     Document Type: Article

References (40)

1. Bodart V, Rainey WE, Fournier A, Ong H, and De Lean A (1996) The H295R human adrenocortical cell line contains functional atrial natriuretic peptide receptors that inhibit aldosterone biosynthesis. Mol Cell Endocrinol 118:137-144.
2. Brown RJ, Adams JJ, Pelekanos RA, Wan Y, McKinstry WJ, Palethorpe K, Seeber RM, Monks TA, Eidne KA, Parker MW, et al. (2005) Model for growth hormone receptor activation based on subunit rotation within a receptor dimer. Nat Struct Mol Biol 12:814-821.
3. Carpenter KA, Wilkes BC, De Lean A, Fournier A, and Schiller PW (1997) Hydrophobic forces are responsible for the folding of a highly potent natriuretic peptide analogue at a membrane mimetic surface: an NMR study. Biopolymers 42:37-48.
4. Cunningham BC, Ultsch M, de Vos AM, Mulkerrin MG, Clauser KR, and Wells JA (1991) Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-825.
5. Cunningham BC and Wells JA (1993) Comparison of a structural and a functional epitope. J Mol Biol 234:554-563.
6. DeLean A, Munson PJ, and Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102.
7. De Lean A, Hancock AA, and Lefkowitz RJ (1982) Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 21:5-16.
8. de Vos AM, Ultsch M, and Kossiakoff AA (1992) Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312.
9. Duda T, Venkataraman V, Ravichandran S, and Sharma RK (2005) ATP-regulated module (ARM) of the atrial natriuretic factor receptor guanylate cyclase. Peptides 26:969-984.
10. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, and Wells JA (1992) Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677-1680.
11. Gardner DG, Chen S, Glenn DJ, and Grigby CL (2007) Molecular biology of the natriuretic peptide system: implication for physiology and hypertension. Hypertension 49:419-426.
12. He Xl, Chow Dc, Martick MM, and Garcia KC (2001) Allosteric activation of a spring-loaded natriuretic peptide receptor dimer by hormone. Science 293:1657-1662.
13. He XL, Dukkipati A, and Garcia KC (2006) Structural determinants of natriuretic peptide receptor specificity and degeneracy. J Mol Biol 361:698-714.
14. Jewett JRS, Koller KJ, Goeddel DV, and Lowe DG (1993) Hormonal induction of low affinity receptor guanylyl cyclase. EMBO J 12:769-777.
15. Kuhn M (2004) Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol 99:76-82.
16. Jossart C, Coupal M, McNicoll N, Fournier A, Wilkes BC, and De Léan A (2005) Photolabeling study of the ligand binding domain of natriuretic peptide receptor A: development of a model. Biochemistry 44:2397-2408.
17. Joubert S, Jossart C, McNicoll N, and De Lean A (2005) Atrial natriuretic peptide-dependent photolabeling of a regulatory ATP-binding site on the natriuretic peptide receptor-A. FEBS J 272:5572-5583.
18. Joubert S, Labrecque J, and De Lean A (2001) Reduced activity of the NPR-A kinase triggers dephosphorylation and homologous desensitization of the receptor. Biochemistry 40:11096-11105.
19. Joubert S, McNicoll N, and De Lean A (2007) Biochemical and pharmacological characterization of P-site inhibitors on homodimeric guanylyl cyclase domain from natriuretic peptide receptor-A. Biochem Pharmacol 73:954-963.
20. Labrecque J, McNicoll N, Marquis M, and De Léan A (1999) A disulfide-bridged mutant of natriuretic peptide receptor-A displays constitutive activity. Role of receptor dimerization in signal transduction. J Biol Chem 274:9752-9759.
21. Labrecque J, Deschenes J, McNicoll N, and De Lean A (2001) Agonistic induction of a covalent dimer in a mutant of natriuretic peptide receptor-A documents a juxtamembrane interaction that accompanies receptor activation. J Biol Chem 276:8064-8072.
22. Lamken P, Lata S, Gavutis M, and Piehler J (2004) Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers. J Mol Biol 341:303-318.
23. Larose L, McNicoll N, Ong H, and De Lean A (1991) Allosteric modulation by ATP of the bovine adrenal natriuretic factor R1 receptor functions. Biochemistry 30:8990-8995.
24. Lee CY and Burnett JC Jr (2007) Natriuretic peptides and therapeutic applications. Heart Fail Rev 12:131-142.
25. Li B, Tom JY, Oare D, Yen R, Fairbrother WJ, Wells JA, and Cunningham BC (1995) Minimization of a polypeptide hormone. Science 270:1657-1659.
26. Mimeault M, Fournier A, Féthière J, De Léan A (1993) Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype. Mol Pharmacol 43:775-782.
27. Misono KS, Sivasubramanian N, Berkner K, and Zhang X (1999) Expression and purification of the extracellular ligand-binding domain of the atrial natriuretic peptide (ANP) receptor: monovalent binding with ANP induces 2:2 complexes. Biochemistry 38:516-523.
28. Ogawa H, Qiu Y, Ogata CM, and Misono KS (2004) Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain. J Biol Chem 279: 28625-28631.
29. Padayatti PS, Pattanaik P, Ma X, and van den Akker F (2004) Structural insights into the regulation and the activation mechanism of mammalian guanylyl cyclases. Pharmacol Ther 104:83-99.
30. Potter LR, Abbey-Hosch S, and Dickey DM (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27:47-72.
31. Rodbard D (1973) Mathematics of hormone-receptor interaction. I. Basic principles. Adv Exp Med Biol 36:289-326.
32. Rondeau JJ, McNicoll N, Gagnon J, Bouchard N, Ong H, and De Lean A (1995) Stoichiometry of the atrial natriuretic factor-R1 receptor complex in the bovine zona glomerulosa. Biochemistry 34:2130-2136.
33. Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L, Manunta P, Marchitti S, Venturelli V, Bianchi G, et al. (2006) Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 48:499-505.
34. Schlosshauer M and Baker D (2004) Realistic protein-protein association rates from a simple diffusional model neglecting long-range interactions, free energy barriers, and landscape ruggedness. Protein Sci 13:1660-1669.
35. Schoenfeld JR, Sehl P, Quan C, Burnier JP, and Lowe DG (1995) Agonist selectivity for three species of natriuretic peptide receptor-A. Mol Pharmacol 47:172-180.
36. Strain WD (2004) The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure. Int J Clin Pract 58:1081-1087.
37. Syed RS, Reid SW, Li C, Cheetham JC, Aoki KH, Liu B, Zhan H, Osslund TD, Chirino AJ, Zhang J, et al. (1998) Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 395:511-516.
38. Tricerri MA, Behling Agree K, Sanchez SA, Bronski J, and Jonas A (2001) Arrangement of apolipoprotein A-I in reconstituted high-density lipoprotein disks: an alternative model based on fluorescence resonance energy transfer experiments. Biochemistry 40:5065-5074.
39. von Geldern TW, Budzik GP, Dillon TP, Holleman WH, Holst MA, Kiso Y, Novosad EI, Opgenorth TJ, Rockway TW, Thomas AM, et al. (1990) Atrial natriuretic peptide antagonists: biological evaluation and structural correlations. Mol Pharmacol 38:771-778.
40. von Geldern TW, Rockway TW, Davidsen SK, Budzik GP, Bush EN, Chu-Moyer MY, Devine EM Jr, Holleman WH, Johnson MC, Lucas SD, et al. (1992) Small atrial natriuretic peptide analogues: design, synthesis, and structural requirements for guanylate cyclase activation. J Med Chem 35:808-816.